Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes patients.…
Personalize glycemic targets for patients with diabetes
As a clinical pharmacist, people with diabetes will rely on your help to tailor A1c goals…
Think "LOWER IS BETTER" for LDL in high CV risk patients
Overview As a cardiovascular pharmacist, there is an ongoing debate regarding the nece…
Finerenone (Kerendia) role for Diabetic Kidney Disease
As a hospital pharmacist, you will hear about a new medication finerenone ( Kerendia ) f…
Optimize management of CKD in patients with diabetes
As a clinical pharmacist, you should optimize treatment of chronic kidney disease (CKD) i…
Explaining the role of Mounjaro for Type 2 Diabetes
Mounjaro (Tirzepatide): A Novel Approach for Type 2 Diabetes Management As a pharmacy …
Treatment of inpatient HYPERglycemia
New data will fuel debate about sliding scale insulin for inpatient hyperglycemia in pat…
Insulin resistance is a BIG problem
Metabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of …
Wegovy for weight loss
Overview As a nutrition support pharmacist, you’re likely hearing a lot about Wegovy …
Dispense SAXENDA for weight loss
As a community pharmacist, you will hear about using Saxenda for weight loss. Saxenda (l…
Reduce insulin if SAXENDA is used for weight loss
Overview As a nutrition support pharmacist, you will hear more about using Saxenda f…
Compare medications for DIABETIC Neuropathy
Overview Up to 50% of patients with diabetes develop peripheral neuropathy. Tailor medi…
Ensure your DIABETIC patients are on statin
Many eligible adults with diabetes aren’t on a statin . We know that statins reduce card…
Best diet for DIABETIC patients
Overview On WORLD DIABETES DAY (14 November), the question is increasing about what is …